These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 1313905)
1. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. Jin XW; Speck SH J Virol; 1992 May; 66(5):2846-52. PubMed ID: 1313905 [TBL] [Abstract][Full Text] [Related]
2. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells. Schlager S; Speck SH; Woisetschläger M J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690 [TBL] [Abstract][Full Text] [Related]
3. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. Puglielli MT; Woisetschlaeger M; Speck SH J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191 [TBL] [Abstract][Full Text] [Related]
4. Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines. Yoo L; Speck SH J Virol; 2000 Dec; 74(23):11115-20. PubMed ID: 11070007 [TBL] [Abstract][Full Text] [Related]
5. B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1. Yoo LI; Mooney M; Puglielli MT; Speck SH J Virol; 1997 Dec; 71(12):9134-42. PubMed ID: 9371570 [TBL] [Abstract][Full Text] [Related]
6. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection. Woisetschlaeger M; Jin XW; Yandava CN; Furmanski LA; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1991 May; 88(9):3942-6. PubMed ID: 1850841 [TBL] [Abstract][Full Text] [Related]
7. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681 [TBL] [Abstract][Full Text] [Related]
8. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. Sung NS; Kenney S; Gutsch D; Pagano JS J Virol; 1991 May; 65(5):2164-9. PubMed ID: 1850003 [TBL] [Abstract][Full Text] [Related]
9. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines. Schaefer BC; Strominger JL; Speck SH J Virol; 1995 Aug; 69(8):5039-47. PubMed ID: 7609074 [TBL] [Abstract][Full Text] [Related]
10. Deletion of Epstein-Barr virus regulatory sequences upstream of the EBNA gene promoter Wp1 is unfavorable for B-Cell immortalization. Yoo LI; Woloszynek J; Templeton S; Speck SH J Virol; 2002 Nov; 76(22):11763-9. PubMed ID: 12388739 [TBL] [Abstract][Full Text] [Related]
11. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Lupton S; Levine AJ Mol Cell Biol; 1985 Oct; 5(10):2533-42. PubMed ID: 3016506 [TBL] [Abstract][Full Text] [Related]
12. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the deletion and rearrangement in the BamHI C region of the X50-7 Epstein-Barr virus genome, a mutant viral strain which exhibits constitutive BamHI W promoter activity. Yandava CN; Speck SH J Virol; 1992 Sep; 66(9):5646-50. PubMed ID: 1323716 [TBL] [Abstract][Full Text] [Related]
14. Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes. Rooney CM; Brimmell M; Buschle M; Allan G; Farrell PJ; Kolman JL J Virol; 1992 Jan; 66(1):496-504. PubMed ID: 1309259 [TBL] [Abstract][Full Text] [Related]
15. Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines. Jansson A; Masucci M; Rymo L J Virol; 1992 Jan; 66(1):62-9. PubMed ID: 1370095 [TBL] [Abstract][Full Text] [Related]
16. Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes. Taylor KA; Wetzel S; Lyles DS; Pollok BA J Virol; 1994 Oct; 68(10):6421-31. PubMed ID: 8083980 [TBL] [Abstract][Full Text] [Related]
17. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Woisetschlaeger M; Yandava CN; Furmanski LA; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1725-9. PubMed ID: 2155423 [TBL] [Abstract][Full Text] [Related]
18. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421 [TBL] [Abstract][Full Text] [Related]
19. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Ling PD; Rawlins DR; Hayward SD Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9237-41. PubMed ID: 8415684 [TBL] [Abstract][Full Text] [Related]
20. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Schaefer BC; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10565-9. PubMed ID: 7479841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]